Welcome to our dedicated page for Jupiter Wellness news (Ticker: jupw), a resource for investors and traders seeking the latest updates and insights on Jupiter Wellness stock.
Jupiter Wellness, Inc. (symbol: JUPW) is a pioneering company in the consumer product development sector, focusing on hemp-derived cannabidiol (CBD) solutions. Founded in 2018 and headquartered in Jupiter, Florida, the company aims to harness the therapeutic potential of CBD to address various medical conditions and ailments including cancer, arthritis, anxiety, insomnia, psoriasis, and chronic pain.
Jupiter Wellness markets CBD-infused sun care lotions under the Canisun brand, offering formulations with various sun protection factors. Additionally, the company is expanding its product range with CBD-infused skincare products under the Caniskin brand and advanced dermatological treatments under the CanidermRx brand.
By integrating CBD's therapeutic properties into everyday wellness products, Jupiter Wellness is at the forefront of a rapidly growing industry. The company continues to achieve significant milestones, driven by ongoing research and development, strategic partnerships, and a commitment to providing innovative solutions for health and wellness.
For further information, Jupiter Wellness can be contacted at:
- Phone: 561-244-7100
- Email: info@JupiterWellness.com
Jupiter Wellness, Inc. (NASDAQ:JUPW) announced that its subsidiary SRM Entertainment is set to achieve its highest monthly sales since its acquisition in December 2020. As theme parks and hospitality industries recover, SRM is experiencing a surge in purchase orders and shipments. CEO Brian John emphasized their strategic investment in these sectors during the pandemic and highlighted the resurgence of family enjoyment in large venues. Jupiter Wellness specializes in CBD-based pharmaceuticals, particularly for skin health, with four significant treatments currently in clinical trials.
Jupiter Wellness, Inc. (NASDAQ:JUPW) has launched a new e-commerce website at CBDcaring.com to enhance accessibility to its growing portfolio of CBD wellness products. This user-friendly site showcases topical skincare brands formulated for therapeutic relief, featuring updated product pages for easy one-click shopping. CEO Brian John expressed enthusiasm for the launch, highlighting the site as a platform for their expanding brand assortment. Jupiter Wellness focuses on CBD-based medical therapeutics, with treatments in skin health for conditions like eczema and skin cancer.
Jupiter Wellness (NASDAQ:JUPW) announced positive results from a clinical study on JW-100, a CBD and aspartame topical formulation for eczema. The study revealed that 50% of subjects using JW-100 showed significant improvement, achieving an ISGA score of clear or almost clear after two weeks, compared to only 20% in the CBD-only group and 15% in the placebo group. Jupiter plans to file an IND application with the FDA, positioning itself well in the $10 billion eczema market.
Jupiter Wellness (NASDAQ:JUPW) has appointed Nancy Torres Kaufman to its board of directors. Kaufman is the founder and CEO of Beacon Capital, which has helped guide 39 life sciences companies, raising $1.5 billion. Her expertise in identifying high-impact firms aligns with Jupiter's goals to advance its clinical pipeline and expand its OTC product offerings. Kaufman emphasized her commitment to sustainable and innovative healthcare solutions, highlighting Jupiter's diverse CBD product portfolio and ongoing FDA clinical trials.
Jupiter Wellness (NASDAQ:JUPW) has completed enrollment for its clinical study on JW-100, a CBD lotion designed to treat atopic dermatitis (eczema), involving 66 patients. The study is double-blinded and placebo-controlled, with a primary endpoint focused on the Investigator's Static Global Assessment (ISGA) score at 29 days. Final results are expected in Q1 2021. CEO Brian John indicated that if successful, the data will be used for an IND application with the FDA, positioning the company to tap into the $10 billion eczema market.
Jupiter Wellness (NASDAQ:JUPW) is set to showcase its Canisun CBD-infused sunscreen at the Surf Expo 2021, happening January 6-8 in Orlando, Florida. This trade show is a key platform for connecting with over 28,000 buyers in the watersports and resort lifestyle sectors. The Canisun line is backed by clinical studies demonstrating its UV protection benefits. This event aims to enhance distribution channels, following the recent acquisition of SRM Entertainment, facilitating relationships with global theme parks and resorts.
Jupiter Wellness, Inc. (NASDAQ: JUPW) has released a new video interview with CEO Brian John and Chief Scientific Officer Dr. Glynn Wilson on SNN Network. This interview emphasizes Jupiter's dedication to developing proprietary CBD sun care and skin care products, targeting medical applications such as eczema and skin cancer. The company is experiencing growth in its over-the-counter skincare product line, including its flagship CaniSun™ sunscreen. Investors can follow further updates and details through the company's website.
Jupiter Wellness (Nasdaq: JUPW) has announced a clinical study for its CaniSun sunscreen, targeting actinic keratosis (AK), a prevalent skin condition. The study will involve 116 adults diagnosed with AK, assessing the efficacy of CaniSun in both treatment and prevention. Current AK treatments often involve surgeries or medications with side effects. CaniSun aims to provide a less invasive alternative, potentially reducing the risk of progression to squamous cell carcinoma. CEO Brian John highlights the opportunity to gather significant patient data from this evaluation.
Jupiter Wellness (NASDAQ:JUPW) announced a multi-year endorsement agreement with World Golf Hall of Famer Ernie Els. This partnership will promote the company's CaniSun, CaniSkin, and CaniDermRx brands. Els, a celebrated golfer with 72 professional wins, highlighted his positive experience with CaniSun sunscreen. Brian John, CEO of Jupiter Wellness, expressed excitement over Els's endorsement, viewing it as validation of their product quality. The company focuses on innovative sun and skin care products, aiming to address various skin-related conditions.
Jupiter Wellness (NASDAQ:JUPW) has announced the initiation of an exploratory clinical study for its topical cream candidate CaniDermRx, aimed at treating first-degree burns. This study, which will be conducted in Europe and Asia, plans to recruit 50 patients and will measure the time to full re-epithelialization of burn wounds. The data collected will be critical for a future IND filing with the FDA. CEO Brian John emphasized the increasing global burn cases and the potential healing benefits of CaniDermRx's dual active ingredients, CBD and aspartame.
FAQ
What is the market cap of Jupiter Wellness (jupw)?
What does Jupiter Wellness, Inc. specialize in?
What are some of the ailments Jupiter Wellness's products aim to treat?
What brands are under Jupiter Wellness, Inc.?
When was Jupiter Wellness, Inc. founded?
Where is Jupiter Wellness, Inc. headquartered?
How can I contact Jupiter Wellness, Inc.?
What is the stock symbol for Jupiter Wellness, Inc.?
Are Jupiter Wellness's products based on CBD?
What is the Canisun brand known for?
What recent achievements has Jupiter Wellness, Inc. made?
